Biotech · Private company
Taiga Biotechnologies, Inc.
Track this companyFree. Adds Taiga Biotechnologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- TBX-3400Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- TBX-3400Phase 1 · Stage III MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard TherapiesPHASE1_PHASE2 · UNKNOWN · started Jan 25, 2021ClinicalTrials.gov NCT04640246 · fetched Nov 12, 2026
- Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint InhibitorsPHASE1 · UNKNOWN · started Jun 2, 2019ClinicalTrials.gov NCT03385486 · fetched Nov 12, 2026